Acute kidney injury subsequent to cardiac surgery

Journal of Extra-Corporeal Technology

Volumn 47, Issue 1, 2015, Pages 16-28

  Kramer, Robert S ^a   Herron, Crystal R ^a   Groom, Robert C ^a   Brown, Jeremiah R ^b  

^a MAINE MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Cardiopulmonary bypass; Ischemia; Kidney injury; Perfusion

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLENE BLUE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; ANEMIA; AUTOREGULATION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CRYSTALLOID; ELECTROLYTE BALANCE; ERYTHROCYTE TRANSFUSION; GENETIC PREDISPOSITION; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEMATOCRIT; HEREDITY; HUMAN; IDEAL BODY WEIGHT; INCIDENCE; INFLAMMATION; INTRAOPERATIVE PERIOD; LONG TERM SURVIVAL; MODIFIED ULTRAFILTRATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREDICTION; PREOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; REVIEW; RISK FACTOR; SURGICAL MORTALITY; TIME TO TREATMENT; VASOPLEGIA; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; MORTALITY; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK ASSESSMENT; SURVIVAL RATE;

ACUTE KIDNEY INJURY; CARDIAC SURGICAL PROCEDURES; HUMANS; INCIDENCE; PATIENT-CENTERED CARE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84975503495     PISSN: None     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3:844-61
2. Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90:1142-9
3. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19-32
4. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444-53
5. Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249:851-8
6. Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds. Committee on the Learning Health Care System in America; Institute of Medicine. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: Institute of Medicine of the National Academies; 2012:50
7. Roy AK, McGorrian C, Treacy C, et al. A comparison of traditional and novel definitions (RIFLE, AKIN, and KIDGO) of acute kidney injury of the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med. 2013;3:26-37
8. Shann KG, Likosky DS, Murkin JM, et al. An evidence based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283-90
9. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter. 2012;2(Suppl):1-138
10. Tolpin DA, Collard CD, Lee VV, et al. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012;143:682-8
11. Brown JR, Cochran RP, Leavitt BJ, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116(Suppl I):I-139-43
12. Karkouti K, Duminda N, Wijeysundera, et al. Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation. 2009;119:495-502
13. Mehran R, Aymong ED, Nicolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44:1393-9
14. Steroids In caRdiac Surgery Trial (SIRS Trial) ClinicalTrials.gov Identifier: NCT00427388
15. Jouan J, Golmard L, Benhamouda N, et al. Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;144:467-73
16. Karkouti K, Duminda N, Wijeysundera DN, et al. Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation. 2009;119:495-502
17. Medalion B, Cohen H, Assali A, et al. The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2010;139:1488-93
18. MarenziG, Assenelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrastinduced nephropathy and mortality. Ann Intern Med. 2009;150:170-7
19. Brown JR, Robb JF, Block CA, et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv. 2010;3:346-50
20. Kramer RS, Quinn RD, Groom RC, et al. Same admission cardiac catheterization and cardiac surgery: Is there an increased incidence of acute kidney injury? Ann Thorac Surg. 2010;90:1418-24
21. Ranucci M, Ballotta A, Agnelli B, Frigiola A, Menicanti L, Castelvecchio S. Acute kidney injury in patients undergoing cardiac surgery and coronary angiography on the same day. Ann Thorac Surg. 2013;95:513-9
22. Hennessy SA, LaPar DJ, Stukenborg GJ, et al. Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. J Thorac Cardiovasc Surg. 2010;140:1011-7
23. Ranucci M, Romitti F, Isgro G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80:2213-20
24. de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: Time for a goaldirected perfusion management? Crit Care. 2011;15:R192
25. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg. 2003;125:1438-50
26. Surgenor S, DeFoe GR, Fillinger MP, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation. 2006;114 (Suppl I):I-43-8
27. Loor G, Koch CG, Sabik JF III, Li L, Blackstone EH. Implications and management of anemia in cardiac surgery: Current state of knowledge. J Thorac Cardiovasc Surg. 2012;144:538-46
28. Shann KG, Likosky DS, Murkin JM, et al. An evidence based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283-90
29. Cormack JC, Forest RJ, Groom RC, Morton JR. Size makes a difference: Use of a low prime cardiopulmonary bypass circuit and autologous priming in small adults. Perfusion. 2000;15:129-35
30. McCusker K, Vijay V, DeBois W, Helm R, Sistino D. Mast System: A new condensed cardiopulmonary bypass circuit for adult surgery. Perfusion. 2002;16:447-52
31. Salmon A, Karajala-Subramanyam V, Kellum JA. The Kidney in Acute Heart Failure and Cardiogenic Shock in Critical Care Nephrology. Saunders Elsevier; 2009:992
32. Karkouti K, Wijeysundera DN, Yau TM, et al. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: An unblinded randomized pilot clinical trial. Anesthesiology. 2012; 116:613-21
33. Vincent JL, Lelubre C. Preoperative transfusions to limit the deleterious effects of blood transfusions. Anesthesiology. 2012;116:513-4
34. Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100:442-4
35. Liakopoulos O, Choi Y, Haldenwang PL, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30 000 patients. Eur Heart J. 2008;29:1548-59
36. de Azevedo JRA, de Azevedo RP, de Lucena LC, da Costa NNR, da Silva WS. Incidence of glycemic control on the incidence of acute kidney injury in critically ill patients: A comparison of two strategies using the RIFLE criteria. Clinics (Sao Paulo). 2010;65:769-73
37. Mehta R. Glycemic control and critical illness: Is the kidney involved? J Am Soc Nephrol. 2007;18:2623-7
38. Lazar HL, McDonnell M, Chipkin SR, et al. Society of Thoracic Surgeons Practice Guideline Series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663-9
39. Drenger B, Fontes ML, Miao Y, et al. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: Effects on in-hospital morbidity and mortality. Circulation. 2012;126:261-9
40. Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464-71
41. Tuman KJ, McCArthy RJ, O'Connor CJ, Holm WE, Ivankovich AD. Angiotensin converting enzyme inhibitors increase vasoconstrictor requirements after CPB. Anesth Analg. 1995;80:473-9
42. Pigott DW, Nagele C, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoconstrictor requirements. Br J Anaesth. 1999;83:715-20
43. John R, Herzenberg AM. Renal toxicity of therapeutic drugs. J Clin Pathol. 2009;62:505-15
44. Dixit M, Doan T, Kirshchner R, Dixit N. Significant acute kidney injury due to non-steroidal anti-inflammatory drugs: Inpatient setting. Pharmaceuticals (Ott). 2010;3:1279-85
45. Nielsen DV, Fedosova M, Hjortdal V, Jakobsen C. Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis. J Thorac Cardiovasc Surg. 2014;148:1634-9
46. Dacey LJ, DeSimone J, Braxton JH, et al. Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. Ann Thorac Surg. 2003;76:760-4
47. Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103:2-8
48. Ozal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615-9
49. Levin RL, DeGrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496-9
50. Berry SA, Doll MC, McKinley KE, Casale AS, Bothe A Jr. ProvenCare: Quality improvement model for designing highly reliable care in cardiac surgery. Qual Saf Health Care. 2009;18:360-8
51. Kanji HD, Schulze CJ, Hervas-Malo M, et al. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg. 2010;5:71
52. Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B. Renal failure after cardiac surgery: Timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg. 2007;84:1264-71
53. Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery. AKICS Score. Kidney Int. 2007;72:624-31
54. Society of Thoracic Surgeons (STS) Workforce on Evidence Based Surgery. Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91:944-82
55. Belway D, Rubens FD, Wozny D, Henley B, Nathan HJ. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion. 2005;20:237-41
56. Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation. 2007;116 (Suppl):I89-97
57. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm MA. Rational approach to perioperative fluid management. Anesthesiology. 2008;109:723-40
58. Karkouti K, Beattie WS, Wijeysundera DN. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;129: 391-400
59. Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol. 1990; 28:477-86
60. BorgerMA, Ivanov J, Weisel RD, Rao V, Peniston CM. Stroke during coronary bypass surgery: Principal role of cerebralmacroemboli. Eur J Cardiothorac Surg. 2001;19:627-32
61. Nicolosi AC, Aggarwal A, Almassi GH, Olinger GN. Intraoperative epiaortic ultrasound during cardiac surgery. J Card Surg. 1996;11:49-55
62. Royse AG, Royse CF. Epiaortic ultrasound assessment of the aorta in cardiac surgery. Best Pract Res Clin Anaesthesiol. 2009;23:335-41
63. Sylivris S, Calafiore P, Matalanis G, Rosalion A, Yuen HP. The intraoperative assessment of ascending aortic atheroma: Epiaortic imaging is superior to both transesophageal echocardiography and direct palpation. J Cardiothorac Vasc Anesth. 1997;11:704-7
64. Schachner T, Nagele G, Kacani A, Laufer G, Bonatti J. Factors associated with presence of ascending aortic atherosclerosis in CABG patients. Ann Thorac Surg. 2004;78:2028-32, discussion 2032
65. DioDato CP, Likosky DS, DeFoe GR, et al. Cardiopulmonary bypass recommendations in adults: The northern New England experience. J Extra Corpor Technol. 2008;40:16-20
66. Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464-71
67. Newland RF, Tully PJ, Baker RA. Hyperthermic perfusion during cardiopulmonary bypass and postoperative temperature are independent predictors of acute kidney injury following cardiac surgery. Perfusion. 2013;28:223-31
68. Santambrogio L, Leva C, Musazzi G, et al. Determination of pump flow rate during cardiopulmonary bypass in obese patients avoiding hemodilution. J Card Surg. 2009;24:245-9
69. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;22:330-1
70. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery. Anaesthesiology. 2002;97:215-52
71. Frenette AJ, Bouchard J, Bernier P, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: A propensity score analysis. Crit Care. 2014;18:602
72. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011;2
73. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med. 1987;317:150-3
74. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012; 308:1566-72
75. Guidet B, Soni N, Della Rocca G, et al. A balanced view of balanced solutions. Crit Care. 2010;14:325